Senior insider sale
Chief Scientific Officer at TOURMALINE BIO, INC. — senior position signals high conviction
$1.21M
499.97K shares
ILDSTAD SUZANNE plans to sell 499.97K shares of TOURMALINE BIO, INC. valued at approximately $1.21M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Founders Shares
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/30/2018 | Founders Shares N/A | 250K | — |
| Total | 250K | ||
Completed
Units to sell
15K
Market value
$35.2K
Units to sell
46.99K
Market value
$109.3K
Units to sell
21.75K
Market value
$47.1K
Units to sell
49.21K
Market value
$105.8K
Units to sell
99.77K
Market value
$213.5K
Units to sell
10.44K
Market value
$21.5K
Units to sell
6.81K
Market value
$14.0K
Planned — Approximate Date
Units to sell
250K
Market value
$662.5K
Units
499.97K
Value
$1.21M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/21/2023 | 15K | $35.2K | — | Completed |
4/20/2023 | 46.99K | $109.3K | — | Completed |
4/19/2023 | 21.75K | $47.1K | — | Completed |
4/18/2023 | 49.21K | $105.8K | — | Completed |
4/17/2023 | 99.77K | $213.5K | — | Completed |
3/17/2023 | 10.44K | $21.5K | — | Completed |
3/3/2023 | 6.81K | $14.0K | — | Completed |
| Planned — Approximate Date | ||||
6/1/2023 | 250K | $662.5K | NASDAQ | Planned |
| Total | 499.97K | $1.21M | ||